Physician profile
Keith Girton
NPI 1023053535
$6,958.41
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,879 · 2020: $1,295 · 2021: $453 · 2022: $261 · 2023: $3,048 · 2024: $22.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,785 · Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,784.50 |
| Food and Beverage | $286.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,974.97 | 2020-2023 | Omnia, Senza |
| Abbott Laboratories | $1,890.82 | 2019-2020 | |
| Si-Bone, INC. | $1,150.53 | 2019-2023 | |
| Smith+Nephew, INC. | $282.48 | 2021 | |
| Medtronic, INC. | $125.75 | 2022 | |
| Zimmer Biomet Holdings, INC. | $95.82 | 2021 | |
| Tersera Therapeutics LLC | $77.99 | 2019-2020 | |
| Boston Scientific Corporation | $70.48 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.96 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $47.54 | 2020 | |
| Depuy Synthes Sales INC. | $39.81 | 2021 | |
| Collegium Pharmaceutical, INC. | $36.50 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $31.78 | 2020 | |
| Flowonix Medical Incorporated | $27.58 | 2019 | |
| Kaleo, INC. | $16.88 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $16.33 | 2019 | |
| Medtronic USA, INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Girton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.